An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer

Background and purpose: Pancreatic cancer is a highly aggressive solid tumor of the digestive system, with radical resection being unfeasible in approximately 80% of patients due to the absence of specific clinical manifestations in the early stages. The use of gemcitabine as a first-line chemothera...

Full description

Saved in:
Bibliographic Details
Main Authors: REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng
Format: Article
Language:English
Published: Editorial Office of China Oncology 2024-12-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/CN/10.19401/j.cnki.1007-3639.2024.12.003
Tags: Add Tag
No Tags, Be the first to tag this record!